Logo

Select Language

English

Down Icon

Select Country

Germany

Down Icon

New lipid-lowering drug obicetrapib reduces LDL cholesterol and lipoprotein(a)

New lipid-lowering drug obicetrapib reduces LDL cholesterol and lipoprotein(a)
CETP inhibitors New lipid-lowering drug obicetrapib reduces LDL cholesterol and lipoprotein(a)

Two phase III studies presented at the European Atherosclerosis Congress (EAS) confirm the safety and efficacy of lipid lowering with the CETP inhibitor obicetrapib in patients with high cardiovascular risk.

Arzte zeitung

Arzte zeitung

Similar News

All News
Animated ArrowAnimated ArrowAnimated Arrow
All reports from the Doctors' Day at a glance
Arzte zeitung

All reports from the Doctors' Day at a glance

Interview with the practice manager: It doesn't work without diplomatic skills!
Arzte zeitung

Interview with the practice manager: It doesn't work without diplomatic skills!

Why family doctor Fugmann lets his practice manager control
Arzte zeitung

Why family doctor Fugmann lets his practice manager control

New lipid-lowering drug obicetrapib reduces LDL cholesterol and lipoprotein(a)
Arzte zeitung

New lipid-lowering drug obicetrapib reduces LDL cholesterol and lipoprotein(a)

By up to three years: Vitamin D3 could slow down aging
FOCUS

By up to three years: Vitamin D3 could slow down aging